Report overview
This report contains market size and forecasts of CRISPR Gene Testing and Diagnostics in Global, including the following market information:
Global CRISPR Gene Testing and Diagnostics Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global CRISPR Gene Testing and Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Animals Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of CRISPR Gene Testing and Diagnostics include 10x Genomics, Aelian Biotechnology, Agilent Technologies, Axxam, Beckman Coulter, Becton, Dickinson and Company, Binx Health, bioM?rieux and Bio-Rad Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CRISPR Gene Testing and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR Gene Testing and Diagnostics Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, by Type, 2022 (%)
Animals
Plants
Pathogens
Others
Global CRISPR Gene Testing and Diagnostics Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, by Application, 2022 (%)
Medical Industry
Agriculture
Others
Global CRISPR Gene Testing and Diagnostics Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global CRISPR Gene Testing and Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR Gene Testing and Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CRISPR Gene Testing and Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
Aelian Biotechnology
Agilent Technologies
Axxam
Beckman Coulter
Becton, Dickinson and Company
Binx Health
bioM?rieux
Bio-Rad Laboratories
Caspr Biotech
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Roche
Sherlock Biosciences
Thermo Fisher Scientific
Vivlion
